Invisalign, the popular clear aligner brand owned by Align Technology Inc., has become the subject of multiple lawsuits alleging anticompetitive practices and patent infringement. The most significant legal action is a $31.75 million antitrust settlement that received final approval in November 2025, affecting approximately 1.45 million consumers who purchased clear aligners between 2019 and 2025. This settlement stems from allegations that Align Technology engaged in anticompetitive conduct with SmileDirectClub that artificially inflated prices for clear aligner products—meaning customers potentially overpaid for their treatments due to supposed illegal market manipulation. Beyond the settled antitrust case, a separate direct purchaser lawsuit remains active, with no settlement reached yet.
This pending litigation focuses specifically on individuals who bought Invisalign directly from Align Technology between January 2019 and March 2022. Additionally, Align Technology filed its own patent infringement lawsuit in August 2025 against Shanghai-based competitor Angelalign Technology, demonstrating that legal battles in the clear aligner space extend beyond consumer protections to include intellectual property disputes. The landscape of Invisalign litigation is complex and evolving. For customers who purchased clear aligners during the relevant time periods, understanding which lawsuits may apply to them—and what payments they might receive—requires careful review of the claims deadlines, eligibility requirements, and payout timelines.
Table of Contents
- What Are the Invisalign Class Action Lawsuits?
- The $31.8 Million SmileDirectClub Antitrust Settlement
- Direct Purchaser Lawsuit Against Align Technology
- Patent Infringement Claims and Other Litigation
- Eligibility and Claims Process for the Settlement
- Payout Amounts and Expected Distribution Timeline
- What This Means for Future Invisalign Customers
- Conclusion
What Are the Invisalign Class Action Lawsuits?
Multiple lawsuits have been filed against Align Technology and SmiledirectClub, each addressing different aspects of alleged wrongdoing in the clear aligner market. The most consequential is the antitrust settlement, which alleges that Align Technology and SmileDirectClub engaged in anticompetitive behavior that reduced competition and kept prices artificially high. When two major companies in a market allegedly coordinate or engage in conduct that prevents competitors from entering or competing fairly, it can result in higher prices for consumers—which is precisely what the settlement alleges happened in the clear aligner industry. The antitrust settlement covers the broadest group of consumers: anyone who purchased clear aligner products between 2019 and 2025.
This encompasses not only direct Invisalign customers but also SmileDirectClub users and potentially purchasers from other channels during that window. The settlement amount of $31.75 million was divided among 1.45 million class members, resulting in estimated individual payouts ranging from $40 to $60 per person, with a minimum guaranteed payment of $10 even if claims processing costs exceed projections. Unlike some settlements that may take years to distribute funds, this one moved relatively quickly through the legal system. The claims deadline of October 27, 2025 has already passed, meaning new claims cannot be filed, but those who submitted claims by that date should receive payment in early 2026 once claims processing is completed. This settlement represents one of the clearest paths to compensation for Invisalign customers affected during the alleged anticompetitive period.
The $31.8 Million SmileDirectClub Antitrust Settlement
The antitrust settlement received final approval on November 22, 2025, from U.S. District Judge Vince Chhabria in the Northern District of California. Final approval is a critical milestone because it means the court has determined the settlement is fair, reasonable, and adequate for class members—and that the defendant has agreed to the terms. This eliminates uncertainty about whether the settlement will actually pay out; barring extraordinary circumstances, the money is committed. What makes this settlement significant is not just the dollar amount but what it required Align Technology to admit about its conduct. The settlement resolved allegations that Align Technology and SmileDirectClub engaged in anticompetitive conduct that kept clear aligner prices higher than they would have been in a competitive market.
For consumers, this means if you purchased Invisalign or other clear aligners during the 2019-2025 period, the settlement recognizes you may have paid more than you would have in a fair, competitive marketplace. The settlement compensates class members for that alleged overcharge. One important limitation of this settlement: it does not represent a finding of guilt or wrongdoing by the court. Instead, it is a negotiated resolution where Align Technology neither admits nor denies the allegations. This is a common structure in settlements and allows companies to resolve litigation without acknowledging legal violations. From a consumer perspective, it means the $31.75 million payment is available regardless of future developments in other pending litigation.
Direct Purchaser Lawsuit Against Align Technology
A separate class action lawsuit targets consumers who purchased Invisalign directly from Align Technology between January 1, 2019, and March 31, 2022. This direct purchaser lawsuit is distinct from the SmileDirectClub antitrust settlement because it focuses specifically on Align’s direct sales channels rather than the broader market. The lawsuit alleges similar anticompetitive conduct—that Align Technology engaged in practices that artificially inflated prices for direct Invisalign purchases. As of early 2026, this lawsuit remains in active litigation with no settlement. The case is currently in class certification proceedings and expert discovery, which means the attorneys are still gathering evidence and the court has not yet determined whether the class should be certified for legal proceedings.
No payments have been distributed to class members in this case. This is an important distinction: if you are eligible only for the direct purchaser lawsuit and not the antitrust settlement, you have no guaranteed payment yet, and the timeline for resolution remains uncertain. The direct purchaser lawsuit covers a narrower time window and customer base than the antitrust settlement, making it a more specific claim. However, the narrower scope also means fewer class members will share any eventual settlement, which could result in larger individual payouts if the case succeeds. This also represents a potential risk: if the lawsuit fails or results in a smaller settlement than expected, direct purchasers may recover little or nothing. Currently, ongoing discovery and class certification decisions will determine whether this lawsuit moves forward.
Patent Infringement Claims and Other Litigation
Align Technology itself became a plaintiff when it filed a patent infringement lawsuit on August 18, 2025, against Angelalign Technology, a Shanghai-based manufacturer of clear aligners. This lawsuit is distinct from the consumer-focused cases described above—it addresses whether Angelalign’s products infringe on Align Technology’s patents rather than whether consumers were overcharged. Patent litigation in the dental industry can significantly impact market competition and potentially affect future product availability and pricing. This patent suit illustrates why Invisalign maintains its market dominance: the company has invested heavily in patent protection for its clear aligner technology. When competitors like Angelalign develop similar products, Align Technology uses patent law to protect its intellectual property and market position.
For consumers, patent litigation matters because it can limit the availability of alternative clear aligner products, potentially keeping Invisalign prices higher than they would be with more direct competition. The patent litigation adds another layer to the legal complexity surrounding Invisalign. While the antitrust settlement and direct purchaser lawsuit address whether prices were kept artificially high in the past, the patent litigation may influence future market dynamics. If Align Technology successfully prevents competitors from selling clear aligners that infringe its patents, that could limit options for future customers. Conversely, if competitors develop non-infringing alternatives, customers may have more choices and potentially lower prices.
Eligibility and Claims Process for the Settlement
The SmileDirectClub antitrust settlement has already passed its claims deadline of October 27, 2025. However, understanding eligibility is still important for anyone who may have submitted a claim or wants to verify their status. To be eligible, you must have purchased clear aligner products between 2019 and 2025. This covers Invisalign purchases made directly from Align Technology, through dentists or orthodontists, or from other retailers, as well as SmileDirectClub purchases. Documentation typically required for claims includes proof of purchase—receipts, credit card statements, dental records, or account information showing that you purchased clear aligners during the eligible period.
Claims that were submitted by the October 27, 2025 deadline are now being processed. For anyone who missed the deadline, filing a claim is no longer possible in the SmileDirectClub antitrust settlement. This represents a significant limitation: late claims are not accepted, and there is no extension process once the deadline passes. For the direct purchaser lawsuit, which remains pending with no settlement, eligibility requirements are similar but more specific: you must have purchased Invisalign directly from Align Technology between January 1, 2019, and March 31, 2022. Since this case has not yet settled, there is no claims deadline. However, no payments are being distributed at this time, and the timeline for when or if this lawsuit will settle remains uncertain.
Payout Amounts and Expected Distribution Timeline
The SmileDirectClub antitrust settlement allocates $31.75 million among approximately 1.45 million class members, resulting in average individual payouts of $40 to $60 per person. Every valid claim receives a minimum guaranteed payment of $10, even if administrative costs and processing exceed projections. This means the smallest payouts will not fall below that floor, protecting claimants from receiving minimal amounts after waiting for payment. The actual payout amount you receive depends on how many valid claims are submitted and the final costs of claims administration. If fewer people file claims than expected, the settlement fund will stretch further, and individual payouts may be higher. Conversely, if claims exceed projections, payouts may be closer to the $40 floor.
The expected payout timeline is early 2026, once claims are processed and validated. This relatively quick timeline—approximately six months from final approval to expected distribution—is faster than many class action settlements, which can take years to resolve. One practical consideration: do not expect a large check. The maximum individual payout of $60 reflects the relatively low per-customer overcharge that the settlement compensates for. This is not a settlement where individuals receive thousands of dollars. Instead, it represents a small refund for alleged overcharges accumulated over years of purchases. For customers who purchased multiple Invisalign treatment plans during the period, cumulative overcharges could be larger, but the settlement structure compensates based on the collective impact across all class members rather than individual customer spending.
What This Means for Future Invisalign Customers
The settlement and ongoing litigation do not retroactively fix prices paid by past customers, but they may influence future pricing and market competition. If antitrust enforcement successfully prevents Align Technology from engaging in the alleged anticompetitive conduct, future customers could benefit from more competitive pricing. The patent litigation against Angelalign and other potential competitors will ultimately determine whether customers have access to lower-cost alternatives or remain dependent on Invisalign’s premium pricing.
For current Invisalign customers considering treatment, these lawsuits do not directly affect product safety or efficacy—they address pricing and market competition. Invisalign remains an FDA-cleared medical device, and the lawsuits do not suggest problems with how the aligners work. However, the litigation does highlight that the clear aligner market has been subject to alleged anticompetitive practices, which is relevant context for understanding why Invisalign prices have remained relatively high despite increased competition from companies like SmileDirectClub and other manufacturers.
Conclusion
Invisalign has become the subject of significant litigation addressing both consumer pricing and intellectual property rights. The $31.75 million antitrust settlement that received final approval in November 2025 represents the most concrete compensation available to consumers, covering approximately 1.45 million class members who purchased clear aligners between 2019 and 2025. Anyone who submitted a claim by the October 27, 2025 deadline should expect to receive $40 to $60 in compensation, distributed in early 2026, with a guaranteed minimum of $10 per valid claim.
If you purchased Invisalign or other clear aligners during the relevant periods and submitted a claim before the deadline, monitor your mailbox and email for payout details from the claims administrator in early 2026. If you missed the claims deadline for the antitrust settlement but purchased directly from Align between January 2019 and March 2022, the direct purchaser lawsuit remains active, though no settlement or timeline for resolution has been announced. For future Invisalign customers, these legal actions represent efforts to ensure fair market competition and pricing in the clear aligner industry.